# 2025年12月7日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 复发性 GABRG2 p.(Ala106Thr) 功能获得型变异个体的早期神经症状与癫痫结局：结构与表型的洞见

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41351427)
**期刊：** Epilepsia
**PMID：** 41351427
**DOI：** 10.1111/epi.70045

### 第一部分 原文与翻译

**英文原标题：** Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.(Ala106Thr) gain-of-function variant: Structural and phenotypic insights.

> **英文摘要：**
> OBJECTIVE: Variants in GABRG2, encoding the γ2 subunit of the γ-aminobutyric acid type A receptor, are linked to epilepsy phenotypes of varying severity, with gain-of-function (GoF) variants associated with the more severe phenotypes than loss-of-function variants. Here, we provide a comprehensive analysis of the early clinical features, motor, language, and eating abilities, and structural consequences of the recurrent GABRG2 p.(Ala106Thr) GoF variant, aiming to refine genotype-phenotype correlations and deepen the understanding of GoF-associated GABRG2 disorders.
> 
> METHODS: Individuals were recruited through international collaborations, literature review, and patient advocacy groups. Clinical data were collected via standardized interviews and physician reports. Functional effects were assessed using electrophysiological recordings. Structural modeling was performed using homology-based approaches to evaluate conformational changes.
> 
> RESULTS: We collected 23 unrelated individuals harboring the GABRG2 p.(Ala106Thr) variant. Symptoms began with early dysphagia (median onset age = 1 month), hypotonia, seizures (median onset age = 2 months), and hyperkinetic movement disorders (median onset age = 3 months). Epilepsy was present in 91% of the individuals, 71% featuring a developmental and epileptic encephalopathy; 33% of the individuals with epilepsy achieved seizure freedom during the follow-up. All individuals exhibited moderate to severe cognitive/neurodevelopmental impairment, with profound deficits in motor, language, and other domains. Functional analysis confirmed a GoF effect of the p.(Ala106Thr) variant. By contrast, another variant affecting the same residue, p.(Ala106Pro), which is observed in population databases, was functionally characterized as neutral. Structural modeling indicated that the p.(Ala106Thr) variant may enhance receptor gating by facilitating a hydrogen bond between the extracellular and transmembrane domains, a mechanism not observed with the p.(Ala106Pro) variant.
> 
> SIGNIFICANCE: Although some individuals exhibited severe developmental impairment without epilepsy, our findings demonstrate that the recurrent GABRG2 p.(Ala106Thr) GoF variant is consistently associated with a severe neurodevelopmental phenotype. Despite its profound clinical impact, in silico tools consistently predict this variant as benign, highlighting a critical gap in current predictive models.

> **中文摘要：**
> 目的：GABRG2 基因编码 γ-氨基丁酸 A 型受体（GABAA 受体）的 γ2 亚基，其变异与不同严重程度的癫痫表型相关，其中功能获得型（GoF）变异通常比功能丧失型变异导致更为严重的表型。本研究对复发性 GABRG2 p.(Ala106Thr) 功能获得型变异的早期临床特征、运动、语言及进食能力以及结构学后果进行了系统分析，旨在细化基因型-表型关联并加深对功能获得型 GABRG2 相关疾病的理解。
> 
> 方法：研究对象通过国际合作、文献检索及患者倡导组织招募。临床数据由标准化访谈与临床医生报告收集。功能效应通过电生理记录进行评估。结构建模基于同源建模方法以评估构象变化。
> 
> 结果：共纳入 23 名携带 GABRG2 p.(Ala106Thr) 变异的无关个体。症状起始表现为早期吞咽困难（中位起病年龄 1 个月）、肌张力低下、癫痫发作（中位起病年龄 2 个月）及高运动性运动障碍（中位起病年龄 3 个月）。91% 的个体患有癫痫，其中 71% 符合发育性及癫痫性脑病，33% 的癫痫患者在随访期间实现发作缓解。所有受试者均表现出中至重度认知与神经发育障碍，伴显著的运动、语言及其他方面的缺陷。功能分析证实 p.(Ala106Thr) 变异具有功能获得效应。相比之下，影响同一残基的另一种在群体数据库中出现的变异 p.(Ala106Pro) 在功能上表现为中性。结构建模显示，p.(Ala106Thr) 变异可能通过促进胞外域与跨膜域间形成氢键来增强受体门控，而该机制在 p.(Ala106Pro) 变异中未被观察到。
> 
> 意义：尽管部分个体表现为严重发育障碍但无癫痫，本研究结果表明复发性 GABRG2 p.(Ala106Thr) 功能获得型变异始终与严重神经发育表型相关。尽管其临床影响深远，当前的计算预测工具仍一致地将该变异评为良性，揭示出现有预测模型中的关键空白。

### 第二部分 AI 大师评价

本研究针对复发性 GABRG2 p.(Ala106Thr) 功能获得型变异进行了临床与结构层面的系统分析，旨在阐明其基因型-表型关系。研究通过国际多中心样本收集及标准化数据分析，发现该变异与早发性吞咽障碍、癫痫及严重神经发育损害密切相关。电生理与结构模型验证了其功能获得特性，揭示胞外域与跨膜域间氢键形成的潜在致病机制。值得注意的是，尽管变异具有显著致病性，常见的计算工具仍将其误判为良性，提示现有生物信息学模型的预测局限。

---

速递结束，祝您工作愉快！